Endometrial antibodies versus CA-125 for the detection of endometriosis

other OA: closed public-domain-us
View on PubMed View at publisher

Abstract

Detection of endometrial antibodies using an indirect immunofluorescence method along with a well-established human endometrial carcinoma cell line was evaluated and compared with CA-125 for detecting endometriosis. Two hundred two patient sera from the infertility, gynecological, and gynecological oncology services were evaluated. The sensitivity for antibody testing was 83.1% with a specificity of 78.8%, in contrast to a sensitivity of 27.3% and a specificity of 82.6% for CA-125. These preliminary findings offer promise that antibody detection methods may be a useful adjunct in the diagnosis of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

MeSH descriptors

Antigens, Tumor-Associated, Carbohydrate Autoantibodies Biomarkers, Tumor Endometriosis Endometrium Uterine Neoplasms Adult Antigens, Tumor-Associated, Carbohydrate Autoantibodies Biomarkers, Tumor Endometriosis Endometriosis Endometriosis Endometrium False Negative Reactions False Positive Reactions Female Fluorescent Antibody Technique Humans Neoplasm Staging

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:12:05.481982+00:00
unpaywall
last seen: 2026-05-16T02:00:00.672124+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine